Lauren Dennison is an Analyst at Catalio Capital Management L.P.
She is currently a Ph.D. candidate in the Cellular and Molecular Medicine program at Johns Hopkins School of Medicine. Lauren works on characterizing the immunomodulatory effects of targeted therapies in order to develop rational drug combinations in gastrointestinal (GI) cancers.
Lauren earned a B.S. in Biochemistry, Molecular Biology and Genetics from the University of Georgia.